ניווט נגישות
Phys תפריט כתבה

High-throughput platform helps engineer fast-acting covalent protein drugs‎

Phys
20:40

A team led by principal investigators Bobo Dang and Ting Zhou at Westlake University/Westlake Laboratory have developed a high-throughput platform for engineering fast-acting covalent protein therapeutics. Their study, titled "A high-throughput selection system for fast-acting covalent protein drugs" published in Science, opens new avenues for next-generation biologics.

דיווח על כתבה זו הסתרת כתבות מאתר זה המשך קריאה באתר המקור